AtriCure Market Cap 2006-2019 | ATRC
AtriCure market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AtriCure market cap as of December 11, 2019 is $1.22B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.218B | $0.202B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $150.160B | 27.39 |
| Medtronic (MDT) | Ireland | $149.747B | 20.69 |
| Stryker (SYK) | United States | $74.065B | 24.90 |
| Boston Scientific (BSX) | United States | $61.077B | 28.83 |
| Baxter (BAX) | United States | $42.381B | 25.70 |
| Essilor Luxottica (ESLOY) | France | $33.712B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.238B | 18.97 |
| Terumo (TRUMY) | Japan | $26.963B | 33.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.222B | 0.00 |
| Coloplast (CLPBY) | Denmark | $24.840B | 38.33 |
| ResMed (RMD) | United States | $21.637B | 39.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.607B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.217B | 0.00 |
| Insulet (PODD) | United States | $11.140B | 529.97 |
| Bio-Rad Laboratories (BIO) | United States | $10.533B | 50.56 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.324B | 13.66 |
| Hill-Rom Holdings (HRC) | United States | $7.238B | 21.34 |
| Canopy Growth (CGC) | Canada | $7.058B | 0.00 |
| Haemonetics (HAE) | United States | $5.958B | 40.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
| NuVasive (NUVA) | United States | $3.840B | 30.24 |
| ICU Medical (ICUI) | United States | $3.692B | 24.07 |
| Neogen (NEOG) | United States | $3.546B | 59.33 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.178B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.061B | 0.00 |
| Quidel (QDEL) | United States | $2.984B | 28.32 |
| Aurora Cannabis (ACB) | Canada | $2.669B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.596B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.423B | 54.70 |
| Cardiovascular Systems (CSII) | United States | $1.542B | 0.00 |
| InMode (INMD) | Israel | $1.364B | 0.00 |
| Aphria (APHA) | $1.230B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.182B | 23.68 |
| Phibro Animal Health (PAHC) | United States | $0.986B | 18.46 |
| NanoString Technologies (NSTG) | United States | $0.908B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.890B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.803B | 20.07 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.803B | 30.76 |
| Quanterix (QTRX) | United States | $0.704B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.697B | 39.17 |
| PetIQ (PETQ) | United States | $0.695B | 16.97 |
| Omeros (OMER) | United States | $0.662B | 0.00 |
| HEXO (HEXO) | $0.563B | 0.00 | |
| Cerus (CERS) | United States | $0.540B | 0.00 |
| Surmodics (SRDX) | United States | $0.532B | 55.32 |
| OraSure Technologies (OSUR) | United States | $0.485B | 29.07 |
| MacroGenics (MGNX) | United States | $0.474B | 0.00 |
| Owens & Minor (OMI) | United States | $0.445B | 16.47 |
| Organigram Holdings (OGI) | Canada | $0.400B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.395B | 13.57 |
| Utah Medical Products (UTMD) | United States | $0.388B | 28.08 |
| BioLife Solutions (BLFS) | United States | $0.309B | 125.75 |
| Zynex (ZYXI) | United States | $0.293B | 33.19 |
| Bovie Medical (APYX) | United States | $0.273B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.265B | 0.00 |
| United Health Products (UEEC) | United States | $0.245B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 25.76 |
| Vapotherm (VAPO) | United States | $0.244B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.239B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.179B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.164B | 824.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.160B | 0.00 |
| Female Health (VERU) | United States | $0.159B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.147B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.132B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.127B | 8.98 |
| Chimerix (CMRX) | United States | $0.116B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 22.91 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.076B | 0.00 |
| Nephros (NEPH) | United States | $0.066B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.063B | 0.00 |
| Surface Oncology (SURF) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.015B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.013B | 0.00 |
| Myomo (MYO) | United States | $0.008B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
